Analyst firms · Stifel · EDIT

Stifel EDIT price target and rating history

Editas Medicine Inc. (EDIT) · Health Care

Stifel rates Editas Medicine Inc. (EDIT) Hold with a $3 price target, as of its latest action on Dec 13, 2024. It has published 3 rating actions on EDIT since September 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a EDIT price target in the last 12 months, the median target is $6.

Current rating

Hold

Price target

$3

Median target, all firms

$6

Actions on EDIT

3

Stifel price target on EDIT

Every Stifel rating on EDIT

• Dec 13, 2024
  DowngradeStifel downgrades to Hold from Buy, price target $11 to $3
• Sep 29, 2023
  UpgradeStifel upgrades to Buy from Hold, price target $9 to $17
• Sep 24, 2021
  InitiateStifel starts coverage at Hold, price target $65

How other firms rate EDIT

Each firm's latest rating and stated target in the last 12 months.

Questions about Stifel and EDIT

What is Stifel's price target for EDIT?

Stifel's latest stated price target for Editas Medicine Inc. (EDIT) is $3, from its action on Dec 13, 2024.

What is Stifel's rating on EDIT?

Stifel rates EDIT Hold, a neutral rating, as of Dec 13, 2024.

When did Stifel last change its view on EDIT?

On Dec 13, 2024, Stifel downgrades to Hold from Buy, price target $11 to $3.

How does Stifel's EDIT target compare with other analysts?

Across 3 firms with a EDIT price target in the last 12 months, the median target is $6.

More EDIT rating histories

• BofA Securities3
• Oppenheimer3

All Stifel ratingsEDIT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.